All News LifeMD, Inc.

Equities

LFMD

US53216B1044

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-09 pm EDT			5-day change	1st Jan Change
9.3 ^USD	-24.57%		-25.54%	+12.18%

May. 09	Cantor Fitzgerald Adjusts LifeMD's Price Target to $15 From $13, Keeps Overweight Rating	MT
May. 08	Transcript : LifeMD, Inc., Q1 2024 Earnings Call, May 08, 2024

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cantor Fitzgerald Adjusts LifeMD's Price Target to $15 From $13, Keeps Overweight Rating	May. 09	MT
Transcript : LifeMD, Inc., Q1 2024 Earnings Call, May 08, 2024	May. 08
Earnings Flash (LFMD) LIFEMD Reports Q1 Revenue $44.1M, vs. Street Est of $42.6M	May. 08	MT
Earnings Flash (LFMD) LIFEMD Posts Q1 EPS $0.01, vs. Street Est of $-0.01	May. 08	MT
LifeMD Reports First Quarter 2024 Results; Raises Full Year Revenue Guidance	May. 08	AQ
LifeMD, Inc. Provides Financial Guidance for the Second Quarter of 2024	May. 08	CI
LifeMD, Inc. Revises Financial Guidance for the Full Year of 2024	May. 08	CI
Purcell & Lefkowitz LLP Announces Shareholder Investigation of LifeMD, Inc. (NASDAQ: LFMD)	May. 08	PR
LifeMD Becomes the First Virtual Primary Care Provider to Elevate GLP-1 Patient Care with Real-time, At-Home Monitoring of Blood Pressure and Body Composition	May. 02	AQ
LifeMD, Inc. Announces A New Strategic Partnership Designed to Revolutionize Weight Management Patient Care	May. 02	CI
LifeMD Appoints Dr. Calum MacRae to its Board of Directors	Apr. 29	AQ
LifeMD, Inc. Appoints Calum Macrae to Its Board of Directors	Apr. 29	CI
LifeMD to Report First Quarter 2024 Financial Results on May 8	Apr. 24	AQ
BTIG Adjusts LifeMD's Price Target to $14 From $13, Keeps Buy Rating	Apr. 23	MT
LifeMD to Participate in Upcoming Investor and Industry Conferences During May	Apr. 23	AQ
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock	Mar. 26	AQ
LifeMD to Participate in the 23rd Annual Needham Virtual Healthcare Conference	Mar. 25	AQ
LifeMD : 2024 LifeMD Shareholder Letter	Mar. 15	PU
Craig-Hallum Adjusts LifeMD's Price Target to $15 From $10, Maintains Buy Rating	Mar. 12	MT
Cantor Fitzgerald Adjusts Price Target on LifeMD to $11 From $9, Maintains Overweight Rating	Mar. 12	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News LifeMD, Inc.

Equities

LFMD

US53216B1044

All News

Filters